Cargando…
Linear B-Cell Epitopes in Human Norovirus GII.4 Capsid Protein Elicit Blockade Antibodies
Human norovirus (HuNoV) is the leading cause of nonbacterial gastroenteritis worldwide with the GII.4 genotype accounting for over 80% of infections. The major capsid protein of GII.4 variants is evolving rapidly, resulting in new epidemic variants with altered antigenic potentials that must be cons...
Autores principales: | Moeini, Hassan, Afridi, Suliman Qadir, Donakonda, Sainitin, Knolle, Percy A., Protzer, Ulrike, Hoffmann, Dieter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7830539/ https://www.ncbi.nlm.nih.gov/pubmed/33466932 http://dx.doi.org/10.3390/vaccines9010052 |
Ejemplares similares
-
Prolonged norovirus infections correlate to quasispecies evolution resulting in structural changes of surface-exposed epitopes
por: Afridi, Suliman Qadir, et al.
Publicado: (2021) -
Identification of Human Norovirus GII.3 Blockade Antibody Epitopes
por: Yi, Yufang, et al.
Publicado: (2021) -
Identification of a blockade epitope of human norovirus GII.17
por: Yi, Yufang, et al.
Publicado: (2021) -
Identification of a GII.6 norovirus blockade antibody epitope
por: Huo, Yuqi, et al.
Publicado: (2023) -
Montelukast is a dual-purpose inhibitor of SARS-CoV-2 infection and virus-induced IL-6 expression identified by structure-based drug repurposing
por: Luedemann, Max, et al.
Publicado: (2022)